Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07NAJ
|
||||
| Former ID |
DAP000131
|
||||
| Drug Name |
Chloroprocaine
|
||||
| Synonyms |
Chloroprocain; Chloroprocainum; Chlorprocaine; Chlorprocainum; Cloroprocaina; Halestyn; Nesacaine; Piocaine; Chloroprocaine [INN]; Chloroprocaine hydrochloride; Nesacaine MPF; Chlor-procaine; Chloroprocaine (INN); Chloroprocainum [INN-Latin]; Cloroprocaina [INN-Spanish]; Nesacaine (TN); Nesacaine-Ce; Nesacaine-MPF (TN); Benzoic acid, 4-amino-2-chloro-, 2-(diethylamino)ethyl ester; 2-(Diethylamino)ethyl 4-amino-2-chlorobenzoate; 2-(Diethylaminoethyl)-4-amino-2-chlorobenzoate; 2-Chloroprocaine; 2-diethylaminoethyl 4-amino-2-chlorobenzoate; 4-amino-2-chlorobenzoic acid 2-(diethylamino)ethyl ester
|
||||
| Drug Type |
Small molecular drug
|
||||
| Therapeutic Class |
Anesthetics
|
||||
| Company |
Abbott Laboratories
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C13H19ClN2O2
|
||||
| InChI |
InChI=1S/C13H19ClN2O2/c1-3-16(4-2)7-8-18-13(17)11-6-5-10(15)9-12(11)14/h5-6,9H,3-4,7-8,15H2,1-2H3
|
||||
| InChIKey |
VDANGULDQQJODZ-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 133-16-4
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
10079, 6867171, 7978920, 8156087, 10506786, 14848393, 29227282, 46508245, 48415759, 49885651, 50737810, 51091980, 57325131, 93581328, 104318307, 126408473, 129457573, 134222419, 134337453, 134974415, 136933656, 137005484, 140603029, 146711553, 160964495, 163192240, 175265449, 178103720, 179225188, 226398150, 249950684, 251916823, 251918062, 252332530
|
||||
| SuperDrug ATC ID |
N01BA04
|
||||
| SuperDrug CAS ID |
cas=000133164
|
||||
| Target and Pathway | |||||
| Target(s) | Sodium/potassium-transporting ATPase alpha-1 chain | Target Info | Blocker | [535175] | |
| KEGG Pathway | cGMP-PKG signaling pathway | ||||
| cAMP signaling pathway | |||||
| Cardiac muscle contraction | |||||
| Adrenergic signaling in cardiomyocytes | |||||
| Insulin secretion | |||||
| Thyroid hormone synthesis | |||||
| Thyroid hormone signaling pathway | |||||
| Aldosterone-regulated sodium reabsorption | |||||
| Endocrine and other factor-regulated calcium reabsorption | |||||
| Proximal tubule bicarbonate reclamation | |||||
| Salivary secretion | |||||
| Gastric acid secretion | |||||
| Pancreatic secretion | |||||
| Carbohydrate digestion and absorption | |||||
| Protein digestion and absorption | |||||
| Bile secretion | |||||
| Mineral absorption | |||||
| Reactome | Ion transport by P-type ATPases | ||||
| WikiPathways | Iron uptake and transport | ||||
| References | |||||
| Ref 538175 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 040273. | ||||
| Ref 542152 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7145). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.